Droupy S, Giuliano F, Cuzin B, Costa P, Vicaut E, Levrat F
Service d'urologie, CHU de Bicêtre, 78, rue du Général-Leclerc, 94270 Le-Kremlin-Bicêtre, France.
Prog Urol. 2009 Dec;19(11):830-8. doi: 10.1016/j.purol.2009.06.012. Epub 2009 Aug 27.
The objective of this survey was to describe medical reasons disclosed by men over 18 years old when visiting an urologist, to estimate the prevalence of male sexual dysfunction (MSD) including erectile dysfunction (ED) and to describe treatment options for ED.
This survey was performed, with Urology French Association (AFU) partnership, in 150 urological clinics, sample representative of urologists in France regarding age, geographical distribution and practice. The survey was proposed to all adults' men consulting a participating urologist the defined day (Tuesday the 19th of June 2007 or an imminent day). A total of 1848 (92.5%) patients agreed to participate; analysis was performed on 1740 patients. Information related to urological disorders, sexual dysfunctions, their treatment and their impact on the patient's life were gathered by a patient auto-questionnaire. Erectile dysfunction was assessed through the single question of John B. McKinlay.
Among patients (mean age 63+/-14 years), 68% (IC95%=[65.2%; 70.7%]) had ED (44% severe); 25% were treated (of which 2/3 with IPDE5 alone or in association). Male sexual dysfunction was the first reason for visiting urologists (14%) following prostatic diseases (62%). About 60% of the patients had already talked about their ED to a physician, who was an urologist in 44.6% of cases. The perspective of living the rest of their life with this trouble was "unacceptable" for 21.1% of patients with ED and "fairly acceptable" for 34.4%.
This first survey in French urologists' community emphasizes the high prevalence male sexual dysfunctions for inpatients visiting their urologists. Despite declared urologists' interest for male sexual dysfunction, the discrepancy between the high prevalence of ED and the low rate of patients consulting for this condition probably explains the low rate of patients using treatments.
本次调查旨在描述18岁以上男性在就诊于泌尿科医生时所披露的医学原因，估计男性性功能障碍（MSD）的患病率，包括勃起功能障碍（ED），并描述ED的治疗选择。
本次调查是与法国泌尿外科学会（AFU）合作，在150家泌尿外科诊所进行的，这些诊所是法国泌尿科医生在年龄、地理分布和业务方面的代表性样本。该调查针对在指定日期（2007年6月19日星期二或临近日期）就诊于参与调查的泌尿科医生的所有成年男性提出。共有1848名（92.5%）患者同意参与；对1740名患者进行了分析。通过患者自填问卷收集了与泌尿系统疾病、性功能障碍、其治疗及其对患者生活的影响相关的信息。勃起功能障碍通过约翰·B·麦金利的单一问题进行评估。
在患者（平均年龄63±14岁）中，68%（95%置信区间=[65.2%；70.7%]）患有ED（44%为重度）；25%接受了治疗（其中2/3单独使用或联合使用磷酸二酯酶5抑制剂）。男性性功能障碍是继前列腺疾病（62%）之后就诊于泌尿科医生的首要原因（14%）。约60%的患者已经向医生谈论过他们的ED，其中44.6%的情况是向泌尿科医生谈论。对于21.1%的ED患者来说，带着这个问题度过余生的前景是“不可接受的”，而对于34.4%的患者来说是“尚可接受的”。
法国泌尿科医生群体中的这项首次调查强调了在就诊于泌尿科医生的住院患者中男性性功能障碍的高患病率。尽管宣称泌尿科医生对男性性功能障碍感兴趣，但ED的高患病率与为此病症咨询的患者低比例之间的差异可能解释了患者使用治疗方法的低比例。
